PCM
CLDI.WS

Prelude Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Prelude Capital Management’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-30,050
Closed -$1.5K – 1423
2022
Q4 		$1.5K Sell
30,050
-22,629
-43% -$1.13K ﹤0.01% 1093
2022
Q3 		$3K Hold
52,679
– – ﹤0.01% 1320
2022
Q2 		$5K Hold
52,679
– – ﹤0.01% 1413
2022
Q1 		$19K Buy
52,679
+30,050
+133% +$10.8K ﹤0.01% 1249
2021
Q4 		$11K Buy
+22,629
New +$11K ﹤0.01% 1493